SG11202003229RA - Methods and compositions for topical delivery - Google Patents
Methods and compositions for topical deliveryInfo
- Publication number
- SG11202003229RA SG11202003229RA SG11202003229RA SG11202003229RA SG11202003229RA SG 11202003229R A SG11202003229R A SG 11202003229RA SG 11202003229R A SG11202003229R A SG 11202003229RA SG 11202003229R A SG11202003229R A SG 11202003229RA SG 11202003229R A SG11202003229R A SG 11202003229RA
- Authority
- SG
- Singapore
- Prior art keywords
- compositions
- methods
- topical delivery
- topical
- delivery
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 230000000699 topical effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762571038P | 2017-10-11 | 2017-10-11 | |
| US201762571049P | 2017-10-11 | 2017-10-11 | |
| US201762571025P | 2017-10-11 | 2017-10-11 | |
| US201762598828P | 2017-12-14 | 2017-12-14 | |
| US201762598796P | 2017-12-14 | 2017-12-14 | |
| US201762598786P | 2017-12-14 | 2017-12-14 | |
| PCT/US2018/055499 WO2019075263A2 (en) | 2017-10-11 | 2018-10-11 | Methods and compositions for topical delivery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202003229RA true SG11202003229RA (en) | 2020-05-28 |
Family
ID=65992336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202003229RA SG11202003229RA (en) | 2017-10-11 | 2018-10-11 | Methods and compositions for topical delivery |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20190105261A1 (en) |
| EP (1) | EP3694489A4 (en) |
| CN (1) | CN111683653A (en) |
| AU (1) | AU2018347514C1 (en) |
| CA (1) | CA3078631A1 (en) |
| IL (1) | IL273823A (en) |
| SG (1) | SG11202003229RA (en) |
| WO (1) | WO2019075263A2 (en) |
Families Citing this family (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008531732A (en) * | 2005-03-03 | 2008-08-14 | ルバンス セラピュティックス インク． | Compositions and methods for topical application and transdermal delivery of botulinum toxin |
| EP3362145B1 (en) | 2015-10-15 | 2021-01-06 | DUSA Pharmaceuticals, Inc. | Adjustable illuminator for photodynamic therapy and diagnosis |
| US10357567B1 (en) * | 2018-01-12 | 2019-07-23 | Dusa Pharmaceuticals, Inc. | Methods for photodynamic therapy |
| US10835504B2 (en) | 2018-04-18 | 2020-11-17 | G&S Laboratories, Inc. | Compositions to treat anal itch |
| US20210228621A1 (en) * | 2018-06-08 | 2021-07-29 | Sumitomo Seika Chemicals Co., Ltd. | Composition for skin wounds |
| US20200046648A1 (en) * | 2018-07-18 | 2020-02-13 | Surender Kharbanda | Polymeric nanoparticles comprising salinomycin |
| US11197841B2 (en) | 2019-07-23 | 2021-12-14 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
| US20200030226A1 (en) | 2018-07-27 | 2020-01-30 | Johnson & Johnson Consumer Inc. | Botanical and bacterial extracts displaying retinol-like activity |
| US10966948B2 (en) | 2019-07-23 | 2021-04-06 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
| CN112739337B (en) | 2018-07-27 | 2024-05-24 | 强生外科视力公司 | Compositions and methods for treating the eye |
| WO2020092546A1 (en) * | 2018-10-30 | 2020-05-07 | Alexion Pharmaceuticals, Inc. | Co-administration of a hyaluronidase and anti-c5 antibody for treatment of complement-associated conditions |
| CN110151592B (en) * | 2019-05-09 | 2022-04-22 | 杭州科腾生物制品有限公司 | Composition and preparation method and application thereof |
| CN112007025B (en) * | 2019-05-30 | 2022-04-19 | 义慧科技(深圳)有限公司 | Application of mirabegron in preparation of medicine for preventing and/or treating malignant tumor |
| WO2020247874A2 (en) * | 2019-06-07 | 2020-12-10 | Diomics Corporation | Topical time release delivery using layered biopolymer |
| US20210000910A1 (en) | 2019-07-03 | 2021-01-07 | Jysk Skin Solutions Pte Ltd | Topical compositions |
| CN110327285A (en) * | 2019-07-15 | 2019-10-15 | 张正华 | The preparation method of Statins ointment and its application in treatment porokeratosis of Mibelli |
| FR3101544B1 (en) * | 2019-10-07 | 2023-09-29 | Sederma Sa | COSMETIC OR DERMATOLOGICAL TREATMENT BASED ON PEPTIDE(S) OF THE SKIN AND ITS PATTERNS |
| CN110731943B (en) * | 2019-10-15 | 2022-02-08 | 河南牧翔动物药业有限公司 | Febuxostat hydrobromide soluble powder and preparation method thereof |
| US12403079B2 (en) | 2019-10-18 | 2025-09-02 | Magic Blue, Llc | Ingredient in sunscreen compositions |
| IL292448A (en) * | 2019-10-22 | 2022-06-01 | Chemistryrx | Oncokinase inhibitor containing compositions for use in treating congenital epidermal and dermal hyperplasia |
| US11969454B2 (en) | 2019-11-19 | 2024-04-30 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
| KR102201133B1 (en) * | 2020-01-31 | 2021-01-11 | 진로사 | Composition for anti-aging and removing localized fat |
| CN111249298B (en) * | 2020-04-08 | 2021-03-12 | 曲阜师范大学 | Anticancer pharmaceutical composition containing maduramicin and cisplatin |
| US11788058B2 (en) * | 2020-05-14 | 2023-10-17 | Nantong University | Protein-modified PLGA microsphere and tissue-engineered nerve constructed therewith |
| CA3178645A1 (en) * | 2020-05-21 | 2021-11-25 | Elizabeth A. MCANINCH | Microneedle device for control of thyroid hormone levels |
| EP4192436A4 (en) * | 2020-08-10 | 2024-10-02 | Ziropa, Inc. | Compositions and methods for topical delivery |
| WO2022040281A1 (en) * | 2020-08-18 | 2022-02-24 | Onchilles Pharma, Inc. | Modified porcine pancreatic elastase proteins |
| US20220054412A1 (en) * | 2020-08-20 | 2022-02-24 | Jason Pool | Topical formulation and methods for neuropathy relief |
| CN112316158B (en) * | 2020-11-19 | 2021-09-21 | 四川大学 | Method for closing antibacterial agent activity in collagen solution by using supermolecule encapsulating agent |
| CN112630207B (en) * | 2020-12-24 | 2021-12-28 | 江南大学 | A rapid detection method for zilpaterol residues in pork |
| WO2022150657A1 (en) * | 2021-01-07 | 2022-07-14 | AB BioInnovations, Inc. | Therapeutic thiazine dye compositions and methods of use |
| CN113018504A (en) * | 2021-03-11 | 2021-06-25 | 华沃生物科技(武汉)有限公司 | Anti-allergic nasal liquid dressing and preparation method thereof |
| CN112972379B (en) * | 2021-03-17 | 2023-04-25 | 项朝荣 | Gamitmycin emulsion, preparation method and application thereof in prevention and treatment of porcine ileitis |
| CN115245351A (en) * | 2021-04-27 | 2022-10-28 | 山东第一医科大学附属皮肤病医院(山东省皮肤病性病防治研究所、山东省皮肤病医院) | Application of skin patch test in preparation of dapsone syndrome diagnostic product |
| WO2022245578A1 (en) * | 2021-05-17 | 2022-11-24 | The Curators Of The University Of Missouri | Au, ag and rich phytochemical payload nanomaterials, antiviral/antibacterial products and synthesis methods |
| CN113304309A (en) * | 2021-06-02 | 2021-08-27 | 青岛大学 | Compound hydrogel patch for wound skin repair and preparation method thereof |
| KR102350612B1 (en) * | 2021-06-09 | 2022-01-11 | 어유정 | cosmetic composition for improving mastitis |
| WO2023287726A1 (en) | 2021-07-12 | 2023-01-19 | Penland Foundation | Treatment of cancer using botulinum toxin and nitrous oxide |
| CN115671267A (en) * | 2021-07-23 | 2023-02-03 | 上海宝济药业有限公司 | Subcutaneous antibiotic pharmaceutical composition |
| CN113588626B (en) * | 2021-08-24 | 2024-05-24 | 上海师范大学 | Raman spectrum detection method for phenylalanine enantiomer |
| CN113621445A (en) * | 2021-09-09 | 2021-11-09 | 泸州市振泽科技有限责任公司 | Crop straw surface wax wetting and destroying preparation and using method thereof |
| US20230111190A1 (en) * | 2021-09-14 | 2023-04-13 | Nulixir Inc. | Oral compositions with improved bioavailability and methods of making the same |
| CN113813230B (en) * | 2021-10-18 | 2023-03-14 | 佛山市南海东方澳龙制药有限公司 | Micro emulsion for gamithromycin injection and preparation method thereof |
| CN115990240A (en) * | 2021-10-20 | 2023-04-21 | 富比积生物科技股份有限公司 | Application of oligopeptide in treating gingivitis, gingival atrophy and repairing oral mucosa |
| US20230129935A1 (en) * | 2021-10-22 | 2023-04-27 | Vaginal Biome Science, Inc. | System, product and method for maintaining the vaginal microbiome |
| CN114015126B (en) * | 2021-10-28 | 2022-08-30 | 南开大学 | Preparation and application of food packaging film material |
| WO2023119230A1 (en) | 2021-12-22 | 2023-06-29 | L'oreal | Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use |
| WO2023130064A2 (en) * | 2021-12-30 | 2023-07-06 | Sincerus Pharmaceuticals, Inc. | Improved anti-aging formula |
| WO2023131872A2 (en) * | 2022-01-04 | 2023-07-13 | Bartov Noa | Rectal administration techniques |
| WO2023133199A1 (en) * | 2022-01-05 | 2023-07-13 | Asymmetric Therapeutics, Llc | Methods and compositions for treatment of cutaneous proliferative disorders and other skin conditions |
| CN114377122B (en) * | 2022-01-18 | 2023-04-07 | 四川大学 | Compound adjuvant based on tetrahedral framework nucleic acid, mRNA vaccine and preparation method and application thereof |
| CN114414809B (en) * | 2022-03-28 | 2022-06-21 | 中元伯瑞生物科技(珠海横琴)有限公司 | Use of biomarkers for diagnosing pneumoconiosis |
| CN117186177B (en) * | 2022-05-31 | 2024-08-23 | 中国农业大学 | Duck blood cell protein peptide with uric acid reducing activity and preparation method thereof |
| US12083204B2 (en) | 2022-06-02 | 2024-09-10 | L'oreal | Topical composition for homeostatic delivery of nitric oxide and uses thereof |
| CN115420692B (en) * | 2022-07-18 | 2025-07-29 | 温州医科大学 | Fe with peroxidase-like catalytic activity3S4CDs nano material and application thereof |
| CN115137667B (en) * | 2022-08-11 | 2024-09-20 | 深圳市宗匠科技有限公司 | Cosmetic composition with penetration promoting effect and application thereof |
| CN115381771A (en) * | 2022-08-30 | 2022-11-25 | 四川博大金点生物技术有限公司 | Tylosin injection and preparation method thereof |
| JP2025527861A (en) * | 2022-09-02 | 2025-08-22 | アールエス・オンコロジー，エルエルシー | Thiostrepton Dosage Regimen |
| CN115770756B (en) * | 2022-12-01 | 2024-09-27 | 九信(武汉)中药研究院有限公司 | Method for reducing ash content of semen cassiae |
| WO2024130106A1 (en) * | 2022-12-16 | 2024-06-20 | The Texas A&M University System | Oxidized carbon nanoparticles for treating oxidative skin disorders |
| WO2024137819A1 (en) * | 2022-12-23 | 2024-06-27 | Annadurai Dharmarajan | Topical workout muscle recovery composition and its method of application |
| WO2024191498A1 (en) * | 2023-03-13 | 2024-09-19 | Board Of Trustees Of The University Of Arkansas | Yeast-microencapsulated larvicide compositions and methods for making and using the same |
| CN116270978A (en) * | 2023-04-04 | 2023-06-23 | 咸丰县妇幼保健院 | External application medicine for treating cervical erosion and preparation method and application thereof |
| CN116496492B (en) * | 2023-04-04 | 2024-09-06 | 兰州大学 | Polyamide-amine dendritic polymer double-modified by phytic acid and polypeptide, and preparation method and application thereof |
| CN116392505A (en) * | 2023-04-10 | 2023-07-07 | 上海市东方医院（同济大学附属东方医院） | Use of molybdenum nanoparticles in the preparation of a medicament for the treatment of hair growth |
| CN117180302B (en) * | 2023-11-06 | 2024-01-12 | 山东中医药大学第二附属医院(山东省中西医结合医院) | Application of polysaccharide in repairing oral mucosa and accelerator prepared from polysaccharide |
| CN117427027B (en) * | 2023-12-21 | 2024-04-23 | 舒芙雅生物科技有限公司 | Acne-removing composition and preparation method thereof |
| CN118161657B (en) * | 2024-02-28 | 2025-07-18 | 浙江来益美生物医药有限公司 | A preparation method of composite hydroxyapatite filler for injection |
| US12357725B1 (en) | 2024-05-30 | 2025-07-15 | King Saud University | Clinical dressing loaded with coffee extract |
| PL449499A1 (en) * | 2024-08-12 | 2025-04-22 | Arletta Olma-Piękoś | Method of producing a set of active substances for medicines and cosmetics, especially for acne-prone skin |
| CN119909013A (en) * | 2025-01-23 | 2025-05-02 | 华中农业大学 | A diclazuril oral nanosuspension with intestinal targeted solubilization and its preparation method and application |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8713747D0 (en) * | 1987-06-12 | 1987-07-15 | Unilever Plc | Skin treatment composition |
| IT1260148B (en) * | 1992-04-17 | 1996-03-28 | Fidia Spa | USE OF HYALURONIC ACID PREPARATIONS FOR THE FORMATION OF BONE TISSUE |
| GB9617671D0 (en) | 1996-08-23 | 1996-10-02 | Microbiological Res Authority | Recombinant toxin fragments |
| US8916539B2 (en) * | 2000-01-10 | 2014-12-23 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of disease |
| MXPA03011987A (en) * | 2003-12-19 | 2005-06-23 | Osio Sancho Alberto | Method for treating presbyopia by inducing changes in the corneal power and physiology. |
| US20070224150A1 (en) * | 2005-03-24 | 2007-09-27 | Yongji Chung | Growth factor for hair and skin treatment |
| US20070020220A1 (en) | 2005-04-27 | 2007-01-25 | Procter & Gamble | Personal care compositions |
| US8642009B2 (en) * | 2005-12-16 | 2014-02-04 | Catherine M. Shachaf | Diagnostic system for the detection of skin cancer |
| US9532943B2 (en) * | 2010-12-20 | 2017-01-03 | Cormatrix Cardiovascular, Inc. | Drug eluting patch for the treatment of localized tissue disease or defect |
| EP2268306A2 (en) * | 2008-03-14 | 2011-01-05 | The Board Of Trustees Of The University Of Illinois | Therapeutic cancer antigens |
| CN102497871B (en) * | 2008-11-14 | 2014-10-15 | 希斯托金公司 | Extracellular matrix compositions for the treatment of cancer |
| US9629856B2 (en) * | 2010-03-03 | 2017-04-25 | Anteis Sa | Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds |
| CH705713B1 (en) * | 2012-09-21 | 2013-05-15 | Labo Cosprophar Ag | Dermocosmetic composition with filling action, useful e.g. for smoothing wrinkles or furrows in epidermis by topical application, comprises mixture containing hyaluronic acids, which includes e.g. hyaluronic acid crosspolymer, and carrier |
| GB201219602D0 (en) | 2012-10-31 | 2012-12-12 | Syntaxin Ltd | Recombinant clostridium botulinum neurotoxins |
| WO2014134532A1 (en) * | 2013-02-28 | 2014-09-04 | Ventrix, Inc. | Methods and compositions for tissue therapy and analysis |
| CA2937036A1 (en) * | 2014-01-31 | 2015-08-06 | Factor Bioscience Inc. | Methods and products for nucleic acid production and delivery |
| CA3020400A1 (en) * | 2016-04-12 | 2017-10-19 | Illustris Pharmaceuticals, Inc. | Compositions for topical application of compounds |
-
2018
- 2018-10-11 CN CN201880075223.0A patent/CN111683653A/en active Pending
- 2018-10-11 EP EP18865817.3A patent/EP3694489A4/en active Pending
- 2018-10-11 WO PCT/US2018/055499 patent/WO2019075263A2/en not_active Ceased
- 2018-10-11 SG SG11202003229RA patent/SG11202003229RA/en unknown
- 2018-10-11 US US16/158,150 patent/US20190105261A1/en active Pending
- 2018-10-11 CA CA3078631A patent/CA3078631A1/en active Pending
- 2018-10-11 AU AU2018347514A patent/AU2018347514C1/en active Active
-
2020
- 2020-04-06 IL IL273823A patent/IL273823A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019075263A3 (en) | 2020-03-26 |
| AU2018347514B2 (en) | 2024-08-01 |
| CN111683653A (en) | 2020-09-18 |
| IL273823A (en) | 2020-05-31 |
| WO2019075263A2 (en) | 2019-04-18 |
| EP3694489A4 (en) | 2021-06-30 |
| AU2018347514C1 (en) | 2025-01-02 |
| EP3694489A2 (en) | 2020-08-19 |
| CA3078631A1 (en) | 2019-04-18 |
| AU2018347514A1 (en) | 2020-05-07 |
| US20190105261A1 (en) | 2019-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273823A (en) | Methods and compositions for topical delivery | |
| ZA202007965B (en) | Topical pharmaceutical compositions | |
| EP3355954A4 (en) | Delivery methods and compositions | |
| IL259576A (en) | Compositions and methods for immunooncology | |
| GB2546350B (en) | Compositions and methods | |
| GB201718876D0 (en) | Antithrombin-heparin compositions and methods | |
| GB201807325D0 (en) | Compositions and methods | |
| ZA201606704B (en) | Topical corticosteroid compositions | |
| IL274524A (en) | Compositions and methods for aquaculturing | |
| IL268583A (en) | Topical formulations and methods | |
| IL265831A (en) | Compositions and methods for protein expression and delivery | |
| SG11202000615VA (en) | Topical composition | |
| ZA202004533B (en) | Skin-brightening compositions and methods | |
| EP3223793A4 (en) | Compositions and methods for delivering a bio-active agent or bio-active agents | |
| IL272944A (en) | Topical compositions | |
| IL268374A (en) | Topical composition | |
| IL272945A (en) | Topical compositions and methods for treatment | |
| PT3373976T (en) | Topical formulations and uses thereof | |
| PL3615005T3 (en) | Compositions and methods for vaccine delivery | |
| GB201713160D0 (en) | Topical composition | |
| GB201512996D0 (en) | Compositions and methods | |
| GB2564026B (en) | Topical composition and delivery system and its use | |
| PL3072529T3 (en) | Composition comprising vemurafenib and hpmc-as | |
| GB201514413D0 (en) | Compositions and methods | |
| HK1259505A1 (en) | Delivery methods and compositions |